epilepsy
FDA clears Marinus’ Ztalmy as first drug for rare epilepsy
Phil Taylor
epilepsy, ganaxolone, Marinus Pharma, rare disease, regulatory approval, Ztalmy
0 Comment
Could Facebook monitoring predict sudden epilepsy death?
Phil Taylor
digital, digital health, epilepsy, Facebook, SUDEP
0 Comment
Wales is first UK country to fund GW’s Epidyolex for tuberous sclerosis
Phil Taylor
Epidyolex, epilepsy, GW Pharma, HEOR, Jazz Pharmaceuticals, Tuberous Sclerosis Complex, Wales
0 Comment
Drug-resistant epilepsy drug Ontozry backed by NICE
Phil Taylor
Angelini Pharma, epilepsy, HEOR, NICE, Ontozry
0 Comment
Patients/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis
The transformation of brain implants
Jessica Hagen
biomarker, epilepsy, neurology, Neurosoft, traumatic brain injury
0 Comment
Jazz lifted by third EU approval for GW Pharma’s Epidyolex
Phil Taylor
cannabis, Epidyolex, epilepsy, EU, GW Pharma, Jazz Pharmaceuticals, rare disease
0 Comment
UCB backs epilepsy-focused digital heath startup Nile AI
Phil Taylor
digital, digital health, epilepsy, neurology, Nile AI, UCB
0 Comment
Israel’s NeuroHelp to trial AI device that predicts epileptic seizures
Richard Staines
artificial intelligence, epilepsy, neurology
0 Comment